HOUSTON, TX -- (MARKET WIRE) -- 11/23/2004 -- Brandywine Business Services Ltd, Inc., (OTC: BYWN), has entered into a preliminary stock exchange agreement with Compound Healthcare, Inc., of Beverly Hills, California, whereby the company will change its management and focus on acquisition opportunities in the healthcare field with emphasis on the worldwide demand for neutraceutical remedies that have undergone clinical trials for safety and effectiveness.
In addition to a wide range of revenue generating acquisition opportunities in the healthcare field in general, Compound Healthcare will focus on the discovery, development and marketing of nutraceutical preparations and supplements. In 2004 consumers around the world will spend an estimated $60 billion on nutraceuticals and there is growing demand for these alternative solutions in light of recent news that has caused consumer concern about the safety and effectiveness of various drugs that may cause dangerous side effects.
Compound Healthcare's strategy is to grow through acquisitions of privately held companies currently generating revenues with strong growth potential that can be better realized as part of a public company. To that end, it is reviewing a number of companies to acquire that will fit into its strategy. Gerald R. Newman, a mergers and acquisitions attorney with more than thirty years of experience will be the newly appointed president and will manage the acquisitions strategy, following the completion of the stock exchange agreement with Brandywine and the name change to Compound Healthcare.
This press release contains "forward-looking statements" within the meaning of the federal securities laws. These forward-looking statements include without limitation, statements regarding the timing of an award, if any. These statements are subject to risks and uncertainties that could cause actual results and events to differ materially from those anticipated. Readers are cautioned not to place undue reliance on these forward-looking statements that speak only as of the date of this release, and the company undertakes no obligation to update publicly any forward-looking statements to reflect new information, events, or circumstances after the date of this release except as required by law.